(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2024/12/30 | 日証協 | 390,047株 | -0.9% | 18,900株 | -95.27% | 371,522株 | -51.38% | 114,788株 | -80.23% |
2024/12/27 | 日証協 | 393,598株 | +19.62% | 399,797株 | +98.89% | 764,065株 | -31.89% | 580,516株 | +220.19% |
2024/12/20 | 日証協 | 329,033株 | +43.73% | 201,014株 | +320.21% | 1,121,858株 | +11.26% | 181,304株 | -65.73% |
2024/12/13 | 日証協 | 228,919株 | -3.58% | 47,836株 | -67.57% | 1,008,302株 | +78.81% | 529,057株 | +685.37% |
2024/12/06 | 日証協 | 237,419株 | -26.32% | 147,490株 | +109.09% | 563,885株 | +1.58% | 67,364株 | +12.41% |
2024/11/29 | 日証協 | 322,219株 | +17.83% | 70,540株 | +3205.53% | 555,139株 | +5.45% | 59,925株 | +293.11% |
2024/11/22 | 日証協 | 273,453株 | -0.28% | 2,134株 | -40.31% | 526,446株 | +0.01% | 15,244株 | -15.9% |
2024/11/15 | 日証協 | 274,220株 | +5.34% | 3,575株 | -51.83% | 526,417株 | -1.09% | 18,126株 | -25.13% |
2024/11/08 | 日証協 | 260,321株 | -1.25% | 7,421株 | +695.39% | 532,202株 | +0.86% | 24,210株 | -34.56% |
2024/11/01 | 日証協 | 263,619株 | -2.66% | 933株 | -74.75% | 527,658株 | +1.75% | 36,997株 | +10.57% |
2024/10/25 | 日証協 | 270,819株 | -8.8% | 3,695株 | -95.61% | 518,594株 | -3.23% | 33,459株 | -43.07% |
2024/10/18 | 日証協 | 296,952株 | +0.24% | 84,183株 | +4561.3% | 535,887株 | +0.28% | 58,776株 | -1.13% |
2024/10/11 | 日証協 | 296,251株 | -15.44% | 1,806株 | -98.93% | 534,396株 | -5.38% | 59,445株 | -38.2% |
2024/10/04 | 日証協 | 350,351株 | +8.48% | 169,081株 | +106.16% | 564,802株 | -1.3% | 96,195株 | +4.91% |
2024/09/27 | 日証協 | 322,964株 | +2.54% | 82,015株 | +987.3% | 572,216株 | +0.57% | 91,692株 | -8.5% |
2024/09/20 | 日証協 | 314,964株 | -5.43% | 7,543株 | -90.52% | 568,966株 | -1.31% | 100,209株 | -19.97% |
2024/09/13 | 日証協 | 333,064株 | -17.45% | 79,546株 | -57.5% | 576,529株 | -2.05% | 125,209株 | -2.27% |
2024/09/06 | 日証協 | 403,465株 | +39% | 187,160株 | +3946.7% | 588,583株 | -1.36% | 128,111株 | -8% |
2024/08/30 | 日証協 | 290,264株 | -1.75% | 4,625株 | +25.24% | 596,722株 | +0.51% | 139,250株 | +3.06% |
※株式分割は考慮していませんのでご注意ください。
Page Top